SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-24-000494
Filing Date
2024-02-01
Accepted
2024-02-01 08:30:25
Documents
16
Period of Report
2024-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm   iXBRL 8-K 21252
  Complete submission text file 0001477932-24-000494.txt   134915

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipix-20240131.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20240131_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20240131_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20240131_pre.xml EX-101.PRE 8249
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20240131_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT ipix_8k_htm.xml XML 3551
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 24585135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)